InvestorsHub Logo
Followers 6
Posts 236
Boards Moderated 0
Alias Born 08/07/2015

Re: XenaLives post# 348511

Wednesday, 02/02/2022 12:19:05 PM

Wednesday, February 02, 2022 12:19:05 PM

Post# of 465336
Totally understand that the FDA is in control and I totally agree that it is the about the science and the impact on the indications, I guess my question is more about whether or not Anavex looks to push up review timelines based on the various options that I mentioned or things like FTD or priority review voucher? Or even if they could use those options potentially.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News